Showing 6,341 - 6,360 results of 12,750 for search '"therapeutics"', query time: 0.11s Refine Results
  1. 6341

    Primary Bronchopulmonary Actinomycosis Masquerading as Lung Cancer: Apropos of Two Cases and Literature Review by Stamatis Katsenos, Iosif Galinos, Panagiota Styliara, Nikoletta Galanopoulou, Konstantinos Psathakis

    Published 2015-01-01
    “…Clinical, imaging, diagnostic, and therapeutical aspects of the disease are discussed, demonstrating the paramount importance of the histological examination of lung tissue specimens in the confirmation of the infection given either its low culture yield or the limited use of new molecular diagnostic tools in routine clinical practice.…”
    Get full text
    Article
  2. 6342

    Positive and Negative Regulation of Cellular Immune Responses in Physiologic Conditions and Diseases by S. Viganò, M. Perreau, G. Pantaleo, A. Harari

    Published 2012-01-01
    “…The potential to revert exhausted or inactivated T-cell responses following selective blocking of their function made these markers interesting targets for therapeutic interventions in patients with persistent viral infections or cancer.…”
    Get full text
    Article
  3. 6343

    Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma by JinSong Li, GuanBo Zhang, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang

    Published 2025-02-01
    “…Recently, advancements in nanotechnology, coupled with a deeper understanding of cancer biology and nano-biological interactions, have led to the development of various nanoparticles aimed at enhancing therapeutic efficacy through specific targeting of tumor tissues. …”
    Get full text
    Article
  4. 6344

    Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat by Jasińska-Stroschein Magdalena, Owczarek Jacek, Wesołowska Anna, Orszulak-Michalak Daria

    Published 2014-09-01
    “…The present study is aimed to assess whether therapeutic regimen provides any benefits. Seven days after pulmonary hypertension induction, hydrophilic rosuvastatin and sildenafil were given for 14 days to male Wistar outbred rats. …”
    Get full text
    Article
  5. 6345

    PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs by Serena Vella, Pier Giulio Conaldi, Tullio Florio, Aldo Pagano

    Published 2016-01-01
    “…Thus, novel diagnostic, prognostic, and therapeutic approaches are required, mainly to improve treatment outcomes of high-risk NB patients. …”
    Get full text
    Article
  6. 6346

    Management of Recurrent Lung Infections in a Case of Hyperimmunoglobulinemia E (or Job’s) Syndrome by M Arsenault, V Echave, C Fish, J-P Praud

    Published 1995-01-01
    “…A concerted medicosurgical therapeutic regimen can control severe pulmonary complications in patients with this rare syndrome.…”
    Get full text
    Article
  7. 6347

    Effects of high-pressure homogenization on phenolics profile, antioxidant activity, α-glucosidase inhibitory activity, and insulin resistance of peach juice during simulated gastro... by Yijin Peng, Shenke Bie, Shengbao Cai, Linyan Zhou, Chaofan Guo

    Published 2025-02-01
    “…These findings highlighted HPH as an innovative strategy for developing functional fruit-based beverages with enhanced nutritional and therapeutic value.…”
    Get full text
    Article
  8. 6348

    A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome by Clara Gallina, Valentina Turinetto, Claudia Giachino

    Published 2015-01-01
    “…In the cardiovascular disease (CVD) field, MSCs-based therapy is the subject of great expectations. Its therapeutic potential has been already shown in several preclinical models and both the safety and efficacy of MSCs-based therapy are being evaluated in humans. …”
    Get full text
    Article
  9. 6349

    Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches by Carmine D'Amico, Manlio Fusciello, Firas Hamdan, Federica D'Alessio, Paolo Bottega, Milda Saklauskaite, Salvatore Russo, Justin Cerioni, Khalil Elbadri, Marianna Kemell, Jouni Hirvonen, Vincenzo Cerullo, Hélder A. Santos

    Published 2025-03-01
    “…Thus, the results of this study demonstrate that the combination of MN technology with PeptiCRAd may provide a safer, more tolerable, and efficient approach to cancer immunotherapy, potentially translatable to other therapeutic applications.…”
    Get full text
    Article
  10. 6350

    PLGA scaffold combined with MSCs transplantation improved neural function and brain tissue structure in rats with traumatic brain injury by Na Xu, Zihuan Sun, Weikang Guan, Yiming Liu, Yun Gao, Chaoxian Yang

    Published 2025-02-01
    “…Overall, the adhesion of MSCs to PLGA can enhance the therapeutic efficacy of PLGA in rats following TBI.…”
    Get full text
    Article
  11. 6351

    Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report by Cynthia A. Jackevicius, Mannhu N. Ton

    Published 2009-01-01
    “…After a total dose reduction of 43%, the INR returned to therapeutic range within two weeks. The Naranjo probability scale revealed a probable adverse reaction of increased anticoagulant effect associated with high dose ketoconazole. …”
    Get full text
    Article
  12. 6352

    Efficacy of Rational Emotive Behaviour Therapy on Religious Intolerance Among Adolescents in Taraba State, Nigeria by Moses Godswill Alhassan, Muhammad Ahmad Baba

    Published 2024-12-01
    “…The study concludes that REBT is an effective therapeutic intervention for reducing religious intolerance and promoting interfaith tolerance among adolescents.…”
    Get full text
    Article
  13. 6353

    Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report by Jialin Qian, Tianqing Chu

    Published 2025-03-01
    “…Exploring the optimal therapeutic regimens for ALK+ NSCLC patients is of crucial clinical significance. …”
    Get full text
    Article
  14. 6354

    Immunopathogenesis of spondyloarthropathies – Concept of major histocompatibility locus-I-opathy by Amlan Kusum Datta, Uddalak Chakraborty, Swati Kumar, Atanu Chandra

    Published 2021-01-01
    “…Further studies are needed for understanding of its therapeutic implication in such diseases.…”
    Get full text
    Article
  15. 6355

    Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes by Gina Manda, Alexandru-Ionel Checherita, Maria Victoria Comanescu, Mihail Eugen Hinescu

    Published 2015-01-01
    “…This will foster the discovery of reliable biomarkers for early diagnosis and prognosis, and will guide the discovery of new therapeutic approaches for personalized medicine in diabetic nephropathy.…”
    Get full text
    Article
  16. 6356

    A Rare Case of Single-Rooted Mandibular Second Molar with Single Canal by Abdulmohsen Alfadley, Ahmad Alquraishi, Yaser Almazrou, Fahd Aljarbou

    Published 2020-01-01
    “…Furthermore, clinicians need to possess the proper knowledge and skills that allow them to utilize the diagnostic and therapeutic tools available at their disposal in order to optimize the quality of care provided to their patients.…”
    Get full text
    Article
  17. 6357

    Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications by Min Li, Lu Ding, Lu Ding, Liyan Cao, Zepeng Zhang, Xueyan Li, Zirui Li, Qinjing Xia, Kai Yin, Siyu Song, Zihan Wang, Haijian Du, Daqing Zhao, Xiangyan Li, Zeyu Wang, Zeyu Wang

    Published 2025-02-01
    “…The adenylate-activated protein kinase (AMPK) signaling pathway is crucial in regulating cellular energy metabolism, marking it as a significant therapeutic target for diabetes and related complications. …”
    Get full text
    Article
  18. 6358

    A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease by Yin-mei Fu, Ming Chen, Ai-jun Liao

    Published 2017-01-01
    “…This study aimed to evaluate the therapeutic value of adalimumab (ADA) for fistula in Crohn’s disease (CD). …”
    Get full text
    Article
  19. 6359

    KL-6 Mucin as Serum Tumor Marker of Metastatic Renal Cancer: A Case Report by Kyohei Ishida, Go Hasegawa, Toshinori Takada, Akira Ogose, Gen Kawaguchi, Yohei Ikeda, Hiroki Nishiyama, Noboru Hara, Tsutomu Nishiyama

    Published 2024-01-01
    “…We encountered a case of metastatic renal cell carcinoma in which the serum level of KL-6, a therapeutic marker, was exceptionally high and fluctuated with the progression of treatment. …”
    Get full text
    Article
  20. 6360

    The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation by Monika Conchon, Sabri S. Sanabani, Israel Bendit, Carla Luana Dinardo, Lucia Dias, Dalton de Alencar Fischer Chamone, Pedro Enrique Dorlhiac-Llacer, Frederico Luiz Dulley

    Published 2009-01-01
    “…All these patients could be evaluated for the therapeutic efficacy. At a mean of follow-up of 1.9 years of therapy, all evaluable patients achieved major molecular response without compromising safety. …”
    Get full text
    Article